Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Biochem ; 50(13-14): 791-793, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28442257

ABSTRACT

BACKGROUND: Cocaine is a well-known risk factor for acute cardiac events, but the effects in users outside of acute events are less clear. We investigated a possible association between cocaine use and the concentration of a novel biomarker for cardiac stress and heart failure, ST2. METHODS: A case-control study was conducted to compare ST2 concentrations by the presence of cocaine in patients presenting for care, but not cardiac care, at an urban safety net hospital. RESULTS: In samples taken from 100 cocaine-positive and 100 cocaine-negative patients, the presence of cocaine was associated with ST2 concentrations>35ng/mL. Serum concentrations of benzoylecgonine, a major cocaine metabolite, were significantly correlated with ST2 concentrations. CONCLUSIONS: Cocaine use is associated with subclinical cardiac stress and damage outside of acute cardiac events. This information could add to better stratification of cocaine users with elevated ST2 concentrations who may be at higher risk for developing heart failure and other cardiac complications.


Subject(s)
Asymptomatic Diseases , Cocaine-Related Disorders/blood , Cocaine/toxicity , Heart Diseases/etiology , Illicit Drugs/toxicity , Interleukin-1 Receptor-Like 1 Protein/blood , Up-Regulation/drug effects , Adult , Asymptomatic Diseases/epidemiology , Biomarkers/blood , Biomarkers/urine , Biotransformation , Case-Control Studies , Cocaine/analogs & derivatives , Cocaine/blood , Cocaine/urine , Cocaine-Related Disorders/physiopathology , Cocaine-Related Disorders/urine , Female , Heart Diseases/chemically induced , Heart Diseases/epidemiology , Heart Diseases/metabolism , Hospitals, General , Humans , Illicit Drugs/urine , Interleukin-1 Receptor-Like 1 Protein/agonists , Interleukin-1 Receptor-Like 1 Protein/chemistry , Male , Middle Aged , Retrospective Studies , Risk , Safety-net Providers , San Francisco/epidemiology , Severity of Illness Index , Solubility , Substance Abuse Detection , Toxicokinetics
2.
Biochem Pharmacol ; 138: 73-80, 2017 08 15.
Article in English | MEDLINE | ID: mdl-28450225

ABSTRACT

BACKGROUND AND PURPOSE: ST2 is one of the interleukin (IL)-1 receptor family members comprising of membrane-bound (ST2L) and soluble (sST2) isoforms. Clinical trials have revealed that serum sST2 levels predict outcome in patient with myocardial infarction or chronic heart failure (HF). Meanwhile, we and others have reported that ablation of ST2 caused exaggerated cardiac remodeling in both ischemic and non-ischemic HF. Here, we tested whether IL-33, the ligand for ST2, protects myocardium against HF induced by mechanical overload using ligand specific knockout (IL-33-/-) mice. METHODS AND RESULTS: Transverse aortic constriction (TAC)/sham surgery were carried out in both IL-33 and WT-littermates. Echocardiographic measurements were performed at frequent interval during the study period. Heart was harvested for RNA and histological measurements. Following mechanical overload by TAC, myocardial mRNA expressions of Th1 cytokines, such as TNF-α were enhanced in IL-33-/- mice than in WT mice. After 8-weeks, IL-33-/- mice exhibited exacerbated left ventricular hypertrophy, increased chamber dilation, reduced fractional shortening, aggravated fibrosis, inflammation, and impaired survival compared with WT littermates. Accordingly, myocardial mRNA expressions of hypertrophic (c-Myc/BNP) molecular markers were also significantly enhanced in IL-33-/- mice than those in WT mice. CONCLUSIONS: We report for the first time that ablation of IL-33 directly and significantly leads to exacerbate cardiac remodeling with impaired cardiac function and survival upon mechanical stress. These data highlight the cardioprotective role of IL-33/ST2 system in the stressed myocardium and reveal a potential therapeutic role for IL-33 in non-ischemic HF.


Subject(s)
Atrial Remodeling , Disease Models, Animal , Heart Failure/metabolism , Interleukin-1 Receptor-Like 1 Protein/agonists , Interleukin-33/metabolism , Myocardium/metabolism , Signal Transduction , Animals , Biomarkers/metabolism , Fibrosis , Gene Expression Regulation , Heart/physiopathology , Heart Failure/etiology , Heart Failure/pathology , Heart Failure/physiopathology , Hypertrophy, Left Ventricular/physiopathology , Interleukin-1 Receptor-Like 1 Protein/metabolism , Interleukin-33/genetics , Ligands , Mice , Mice, Knockout , Myocardium/immunology , Myocardium/pathology , RNA, Messenger/metabolism , Survival Analysis , Th1 Cells/immunology , Th1 Cells/metabolism , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...